Medicine Man Technologies Inc (SHWZ)

[Drugdoctor]

Q4 2021 Financial Summary:

Revenues of $26.5 million grew 234% compared to $7.9 million in Q4 2020
Gross Margin of $12.1 million was 1,856% better than Q4 2020 and 3,798 bps over Q4 2020
Net Income Attributed to Common Shareholders was $5.5 million compared to a Net Loss of ($8.5) million for the same period last year
Adjusted EBITDA of $7.5 million for the quarter was 28.3% of revenue, compared to a loss of ($3.4) million for the same period last year
Cash Flow from operations for the quarter was $52.5 million(1) compared to ($3.5) million for the same period last year
Retail sales for the quarter were $19.6 million and were up 887% when compared to the same period last year
Two year stacked IDs for Q4 2021 compared to Q4 2019 for same store sales(2) were 40.4% and one year IDs(2) were 4.9% comparing Q4 2021 to Q4 2020
Average basket size(2) for Q4 2021 was $59.70 up 12.1% compared to Q4 2020
Recorded customer visits(2) for Q4 2021 totaled 329,357 down 7.2%, compared to Q4 2020